The Pyramis data management solution from Cardiac Science, now in its fifth generation, centralizes ECG, Holter and stress test data. Pyramis is scalable so additional facilities, users, and new devices can be added at any time. The system is also flexible and can add multimodality and HL7 interfaces.
February 17, 2009 - ZOLL Medical Corp. said today Providence Little Company of Mary Medical Center San Pedro in southern California has installed the company’s AutoPulse Noninvasive Cardiac Support Pump for its resuscitative capabilities in the hospital’s emergency department and intensive care unit.
February 17, 2009 – Over the next several weeks, the Healthcare Information and Management Systems Society (HIMSS) is offering several education opportunities for its members on the implications and opportunities of the American Recovery and Reinvestment Act of 2009, expected to include $19 billion for health IT and to be signed into law this week.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 12, 2009 - Dr. Willem Johan Kolff, the world’s most prolific inventor of artificial organs, passed away Feb. 11 at the age of 97 in Philadelphia. Among Dr. Kolff’s many accomplishments were the artificial kidney, heart-lung machine, artificial eye, artificial ear and artificial arm. However, he was best known for his decades of work that led to the Jarvik 7 artificial heart.
February 16, 2009 - Thoratec Corp. and HeartWare International last week entered into a definitive merger agreement under which Thoratec will acquire HeartWare for a about $282 million, and the combined company will offer a broad portfolio of approved blood pumping devices for the treatment of heart failure.
February 16, 2009 - Registration is now open for the Heart Rhythm Society’s free Reality EP Webcast, “Role of 3D ICE and Epicardial Mapping in the Ablation of Ventricular Outflow Tract Tachycardia,” at 7 p.m. EDT Wednesday, March 4.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 16, 2009 - Agfa HealthCare said today it completed the deployment of its IMPAX HeartStation ECG Management System at the National Heart Centre in Singapore.
February 16 - The CYPHER SELECT Plus Sirolimus-eluting Coronary Stent has received CE marking within the European Union (EU) for treatment of patients with diabetes, a complex and often difficult-to-treat patient population.
February 13, 2009 - Roche Diagnostics has agreed to fund two new projects aimed at strengthening the commercial success of the Response Biomedical cardiovascular line of products, which Roche is expected to begin marketing in North America this quarter. Response Biomedical and Roche Diagnostics signed a strategic partnership in June 2008 to commercialize Response's cardiovascular tests.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 13, 2009 – Toshiba America Medical Systems launched the Aquilion Premium CT system with the capability to cover up to 8 cm in a single rotation. The Aquilion Premium rounds out the company’s CT portfolio and is also field-upgradeable to an Aquilion ONE.
February 12, 2009 - Researchers in The Netherlands say the standard of care of using intra-aortic balloon pumps (IABP) in patients with high-risk STEMI does not appear to help patients, according to a meta-analysis conducted by the Department of Cardiology, Academic Medical Center, University of Amsterdam.
February 12, 2009 - Endologix Inc. yesterday said a live-case demonstration of its new IntuiTrak Delivery System was featured at the International Congress XXII Endovascular Interventions conference in Scottsdale, AZ.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 12, 2009 - Sanofi-aventis said yesterday the ATHENA trial was published in the New England Journal of Medicine, which shows its drug Multaq (dronedarone), in addition to standard therapy, significantly reduced the risk of first cardiovascular hospitalization or death by 24 percent in patients with atrial fibrillation (AF)/atrial flutter (AFL) or a recent history of these conditions.
February 12, 2009 - Osiris Therapeutics Inc. yesterday announced final two-year results for the company's trial evaluating Prochymal — a proprietary formulation of adult stem cells — for the treatment of acute myocardial infarction.
February 12, 2009- Transoma Medical’s Sleuth AT (Advanced Trending) cardiac monitoring system, the company’s second-generation wireless, automated implanted cardiac monitoring (ICM) device, has received FDA clearance.